AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Nosocomial Pneumonia After Coronary Artery Bypass Grafting

Recruitingn/aAges 18 Years - anyAllTomsk National Research Medical Center of the Rusโ€ฆ
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Observational studies of patients with coronary artery bypass grafting, associated with an unfavorable cardiopulmonary prognosis for at least one year after surgery. This is Prospective, cohort, unblinded, observational comparable single center clinical trial. To compare the clinical, laboratory (including complete blood count, metabolic panel, and specific cardiac, inflammatory, infectious, and endothelial biomarkers), functional (ECG, echocardiography, ultrasound, spirometry, cardiopulmonary exercise testing), and radiological (chest X-ray/CT) phenotypes in patients with coronary artery bypass grafting with and without non-ventilator-associated postoperative, nosocomial pneumonia; to identify the factors of early and 1-years cardiopulmonary prognosis. Increased risk of cardiovascular outcomes is related with the circulatory arrest, artificial circulation, perioperative trauma and res

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Age 18 years and older. * Myocardial revascularization for CAD via CABG during the current hospitalization, in accordance with the indications defined by the ESC/EACTS Guidelines on Myocardial Revascularization \[DOI: 10.1093/eurheartj/ehy394\]. * Successful transfer from the intensive care unit to a general ward after surgery. * One or more of the risk factor for nosocomial pneumonia \[doi: 10.15829/1560-4071-2024-6094\]. * Signed informed consent for participation in the study. Pre-operative Exclusion Criteria: * Acute coronary syndrome within the last 1 month. * Combined surgical intervention for infective endocarditis. * Combined valve surgery. * Concomitant pulmonary disease requiring respiratory support prior to surgery. * Presence of a tracheostomy. * Participation in another clinical trial at the time of potential inclusion or within the preceding 3 months. * Diagnosis of malignant neoplasms within the last 5 years. * Life duration of less than 1 year. * HIV infection. Peri-operative Exclusion Criteria: * Ventilator-Associated Pneumonia (VAP). * Acute Myocardial Infarction after CABG and before inclusion. * Acute Stroke after CABG and before inclusion. * Pulmonary after CABG and before inclusion. * Pulmonary Edema after CABG and before inclusion. * Acute Respiratory Distress Syndrome (ARDS) after CABG and before inclusion. * Pneumothorax requiring drainage after CABG and before inclusion. * Delirium after CABG and before inclusion. * Chronic Kidney Disease (CKD) Stage 4-5 / Acute Kidney Injury requiring renal replacement therapy or chronic dialysis. * Any perioperative complication requiring the patient's return to the intensive care unit or prolonging the ICU stay beyond 48 hours. * Any other active infectious process at a different site. * Novel Coronavirus Infection (COVID-19).
๐Ÿ’Š

What it tests

  • Clinical, laboratory, and instrumental examination
๐Ÿ“

Where

1 site
Cardiology Research Institute of Tomsk NRMC
Tomsk, Russia
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy